Merck

merck.us · Rahway, United States of America

Merck & Co., Inc. (branded as Merck in the U.S. and Canada) is a global research-driven biopharmaceutical company that discovers, develops, manufactures, and markets prescription medicines, vaccines, biologic therapies, and animal health products. The company serves patients, healthcare providers, governments, and health systems worldwide, generating revenue primarily through the sale of branded pharmaceuticals and vaccines across therapeutic areas such as oncology, vaccines, hospital acute care, immunology, and cardiometabolic disease.

Revenue
$1B+
Employees
5,001+
Founded
1891
Headquarters
Rahway, United States of America

Merck customers on Arbolus

Total customers 27 27 current · 0 former
Reviews growth 13 new reviews since Jun 2026

Customers who reviewed Merck

Seniority of Merck customers

The largest group of people who reviewed Merck holds C-Suite roles (44%), followed by Director (28%) and Manager (28%).

  • C-Suite 44%
  • Director 28%
  • Manager 28%

Customers sample

Operations Manager Director NPS 8 Will renew
Operations Manager Manager NPS 7 Undecided
Operations Manager C-Suite NPS 8 Will renew

Employer names and spend open once the report publishes.

What 27 Arbolus experts think of Merck

Overall sentiment: Positive

NPS scores are strongly positive, with 74% of responses at 8 or above and frequent perfect scores of 10. Renewal intent is affirmative in all cases where data is provided, especially among high spenders and Influencers. Implementation is mostly mature (more-than-a-year for 48%, less-than-a-year for 33%, remaining in Pilot or not sure), indicating stickiness. Key themes include robust satisfaction, minimal churn signals, and high future engagement among core segments.

Tell us when the Merck report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

51 Net Promoter Score, from 27 scored reviews
  • Promoters 14
  • Passives 13
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 63%
  • Will renew 10
  • Undecided 6
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 67% 9 answers
  • Director 67% 3 answers
  • Manager 67% 3 answers
  • Not specified 0% 1 answer
  • 8.8/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

Top alternatives

Most weighed by Merck customers

For people who use Merck

Do you use Merck at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 27 customers of Merck have already contributed

Takes a few minutes. Your identity stays anonymous.